Close to a hundred marginalized Moro villagers in Bangsamoro town in Cotabato benefited from an eye care mission on Monday. Municipal officials and barangay leaders in Kapalawan, one of the eight ...

Nearly a hundred marginalized Moro villagers in a Cotabato town in the Bangsamoro region benefited from an eye care mission ...

Night driving glasses claim to help you see at night when you are behind the wheel. But do they actually work, and are they ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

A new study from the Koret School of Veterinary Medicine at Hebrew University has brought new insights into Florida spot ...

The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

In this Healio Video Perspective from Retina 2025, W. Lloyd Clark, MD, discusses positive results from three clinical trials investigating NT-501 for macular telangiectasia type 2.

Through its ophthalmic program, Mercy Ships provides critical eye surgeries and trains local professionals, ensuring ...

Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...

Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).